Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $13.79M | $12.13M | +13.68% |
Cost of Revenue | $11.17M | $12.45M | -10.30% |
Operating Income | $-96.34M | $-69.86M | -37.89% |
Net Income | $-91.37M | $-65.33M | -39.87% |
EPS (Basic) | $-0.39 | $-0.34 | -14.71% |
EPS (Diluted) | $-0.39 | $-0.34 | -14.71% |
R&D Expense | $67.56M | $46.68M | +44.74% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $557.85M | $627.37M | -11.08% |
Current Assets | $343.62M | $492.13M | -30.18% |
Total Liabilities | $156.7M | $197.19M | -20.54% |
Current Liabilities | $73.92M | $92.15M | -19.78% |
Stockholders' Equity | $401.15M | $430.18M | -6.75% |
Cash & Equivalents | $296.33M | $473.14M | -37.37% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-102.3M | $-73.32M | -39.53% |
Investing Cash Flow | $-6.65M | $-5.34M | -24.59% |
Financing Cash Flow | $13.9M | $1.92M | +623.05% |
D&A | $7.38M | $3.73M | +97.88% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -698.4% | -575.8% | -122.64% |
Net Margin | -662.4% | — | — |
ROE | -22.8% | — | — |
ROA | -16.4% | — | — |
Current Ratio | $4.648 | — | — |
Debt to Equity | $0.391 | — | — |
Other companies in Biotechnology